Oculus Innovative Sciences Inc. (NASDAQ:OCLS) shares traded up 3.4% during mid-day trading on Friday . The stock traded as high as $4.64 and last traded at $4.62, with a volume of 105,976 shares. The stock had previously closed at $4.47.

Several research analysts have recently issued reports on the company. Maxim Group restated a “buy” rating and issued a $3.00 price target on shares of Oculus Innovative Sciences in a research report on Friday, June 17th. Zacks Investment Research lowered Oculus Innovative Sciences from a “hold” rating to a “sell” rating in a report on Tuesday, March 29th.

The firm’s market cap is $19.40 million. The firm has a 50-day moving average of $4.48 and a 200-day moving average of $4.89.

Oculus Innovative Sciences (NASDAQ:OCLS) last announced its quarterly earnings data on Thursday, June 16th. The company reported ($0.16) EPS for the quarter. Equities research analysts predict that Oculus Innovative Sciences Inc. will post ($0.37) EPS for the current year.

Oculus Innovative Sciences, Inc is a specialty device and pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals. The Company offers wound care products which are sold into the human and animal healthcare markets in the United States, Mexico and Europe.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.